BrainStorm Cell Therapeutics to Host KOL Webinar on Current Developments in the Treatment of Amyotrophic Lateral Sclerosis (ALS) on December 11, 2024 (PRNewswire) - Dec 2, 2024 - "BrainStorm Cell Therapeutics Inc...today announced that it will host a key opinion leader (KOL) webinar on Wednesday, December 11, 2024 at 10:00 AM ET. To register, click here. The webinar will feature Dr. Terry Heiman-Patterson...who will discuss the current treatment landscape and advances for patients with amyotrophic lateral sclerosis (ALS). Dr. Heiman-Patterson...who will share updates on the company's planned Phase 3b registrational clinical trial, NurOwn (autologous MSC-NTF cells), and future development plans."
Clinical • Amyotrophic Lateral Sclerosis • CNS Disorders
|